This article is more than 5 years old. Information may no longer be current.

Cancer center, research institute receive new director

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Pier Paolo Pandolfi, MD, PhD has been named director of the Beth Israel Deaconess Medical Center Cancer Center and Cancer Research Institute.

Pandolfi previously served as the chief of the division of genetics in the department of medicine, director of research in the cancer center, and director of the cancer genetics program at Beth Israel Deaconess Medical Center. He also is the George C. Reisman professor of medicine at Harvard Medical School.

“Dr. Pandolfi’s entire career has been motivated by a deep caring for the individual with cancer. He has not only unlocked genetic secrets that led to a cure of [acute promyelocytic leukemia], but he has also made several important discoveries and developed novel methodologies with hopeful implications for treating other cancers,” Kevin Tabb, MD, president and CEO of Beth Israel Deaconess Medical Center, said in a press release. “Dr. Pandolfi is one of the true leaders in the field, and having him head our cancer center puts Beth Israel Deaconess Medical Center in the center of a change in the way clinicians and scientists think about cancer.”